ANALOG PHARMA AND DIPHARMA ANNOUNCE US FDA APPROVAL OF ABBREVIATED NEW DRUG APPLICATION (ANDA) OF GENERIC NITISINONE CAPSULES (TEMPERATURE STABLE)
Analog Pharma (“Analog”) and Dipharma S.A. (“Dipharma”) today announced that their nitisinone abbreviated new drug application (ANDA) has received final approval from the U.S. Food and Drug Administration. Nitisinone Capsules is a room temperature stable, AB-rated, generic equivalent of Swedish Orphan ...
Source: pharmiweb.com